Literature DB >> 24496565

Fractalkine receptor polymorphism and chronic tonsillitis.

Seda Turkoglu Babakurban1, Selim S Erbek, Yunus Kasim Terzi, Fatih Arslan, Feride I Sahin.   

Abstract

The objective of this study is to examine whether there is an association of fractalkine gene receptor polymorphisms with chronic tonsillitis. This is a cross-sectional study in the setting of a tertiary referral center. The study group included 79 patients with chronic tonsillitis and 76 controls without history of chronic tonsillitis. Genotypes were identified by restriction fragment length polymorphism analyses after polymerase chain reaction. c.745G>A (V249I) single nucleotide polymorphism and the frequencies of the G and A alleles did not differ in the patient and control groups (p = 0.363; p = 0.743, respectively). c.839C>T (T280M) single nucleotide polymorphism was found to be higher in controls than in the patients with chronic tonsillitis (p < 0.001). Consistent with this result, T allele frequency was higher in controls than in the patients with chronic tonsillitis (p < 0.001). In this study, we suggested that fractalkine gene receptor c.839C>T (T280M) single nucleotide polymorphism could be associated with a reduced risk of chronic tonsillitis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496565     DOI: 10.1007/s00405-014-2908-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

1.  CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.

Authors:  S Goda; T Imai; O Yoshie; O Yoneda; H Inoue; Y Nagano; T Okazaki; H Imai; E T Bloom; N Domae; H Umehara
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Association study between the CX3CR1 gene and asthma.

Authors:  K Tremblay; M Lemire; V Provost; T Pastinen; Y Renaud; A J Sandford; M Laviolette; T J Hudson; C Laprise
Journal:  Genes Immun       Date:  2006-11-02       Impact factor: 2.676

3.  The role of matrix metalloproteinases in recurrent tonsillitis.

Authors:  Engin Acioglu; Ozgür Yigit; Zeynep Alkan; Ela Araz Server; Hafize Uzun; Ramisa Gelisgen
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-03-15       Impact factor: 1.675

4.  Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.

Authors:  Stephan Brand; Katrin Hofbauer; Julia Dambacher; Fabian Schnitzler; Tanja Staudinger; Simone Pfennig; Julia Seiderer; Cornelia Tillack; Astrid Konrad; Burkhard Göke; Thomas Ochsenkühn; Peter Lohse
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

5.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

6.  Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris.

Authors:  Hideyuki Ikejima; Toshio Imanishi; Hiroto Tsujioka; Manabu Kashiwagi; Akio Kuroi; Takashi Tanimoto; Hironori Kitabata; Kohei Ishibashi; Kenichi Komukai; Tatsuya Takeshita; Takashi Akasaka
Journal:  Circ J       Date:  2009-12-17       Impact factor: 2.993

7.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

Authors:  David H McDermott; Alan M Fong; Qiong Yang; Joan M Sechler; L Adrienne Cupples; Maya N Merrell; Peter W F Wilson; Ralph B D'Agostino; Christopher J O'Donnell; Dhavalkumar D Patel; Philip M Murphy
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

8.  The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.

Authors:  Jean-Marc Sabate; Nejma Ameziane; Jérôme Lamoril; Pauline Jouet; Jean-Pierre Farmachidi; Jean-Claude Soulé; Florence Harnois; Iradj Sobhani; Raymond Jian; Jean-Charles Deybach; Dominique de Prost; Benoit Coffin
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-08       Impact factor: 2.566

9.  Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.

Authors:  Børre Fevang; Arne Yndestad; Jan K Damås; Vigdis Bjerkeli; Thor Ueland; Are M Holm; Klaus Beiske; Pål Aukrust; Stig S Frøland
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

10.  Human beta-Defensins in different states of diseases of the tonsilla palatina.

Authors:  Matthias Schwaab; Andre Gurr; Stefan Hansen; Amir M Minovi; Jan P Thomas; Holger Sudhoff; S Dazert
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-09-02       Impact factor: 2.503

View more
  1 in total

1.  Fractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitis.

Authors:  Hale Gokcan; Erkan Yurtcu; Haldun Selcuk; Feride I Sahin
Journal:  Bosn J Basic Med Sci       Date:  2015-05-25       Impact factor: 3.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.